Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leon, A. S.
Right arrow Articles by Halpern, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leon, A. S.
Right arrow Articles by Halpern, M.
(Chest. 1962;42:626-634.)
© 1962 American College of Chest Physicians

Clinical Observations on Methyclothiazide Alone and with Deserpidine in the Treatment of Hypertension

Arthur S. Leon M.D.1; Martin S. Belle M.D., F.C.C.P.2; and Morton Halpern M.D., F.C.C.P.2

1 University of Miami School of Medicine, Jackson Memorial Hospital, Miami, Florida
2 Miami, Florida

Methyclothiazide, (Enduron) alone and in combination with deserpidine (Harmonyl) proved to be an effective and relatively safe agent in the treatment of 62 ambulant mild to moderately severe hypertensive patients.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1962 by the American College of Chest Physicians.